Key result
Concurrent administration of intravenous magnesium with ibutilide increased the odds of successful chemical conversion of atrial fibrillation or flutter.
Why the study?
Does intravenous magnesium sulfate improve successful chemical conversion in patients receiving intravenous ibutilide for atrial fibrillation or flutter?
Cohort (n=229)
Does intravenous magnesium sulfate improve successful chemical conversion in patients receiving intravenous ibutilide for atrial fibrillation or flutter?
Adjunctive intravenous magnesium sulfate, particularly at a 4-gram dose, significantly increases the efficacy of intravenous ibutilide for the chemical conversion of atrial fibrillation or flutter.
Answers are grounded in this paper and cite their sources.
Magnesium co-administration was associated with higher ibutilide conversion rates; hypothesis-generating and requires randomized confirmation before practice change.
BACKGROUND: A previous randomized trial found that adjunctive use of intravenous magnesium (a total of 4 grams) can attenuate the corrected QT interval (QTc) prolongation associated with ibutilide, but its impact on ibutilide efficacy has not been elucidated. METHODS: This was a cohort evaluation of 229 consecutive patients who received ibutilide in the presence or absence of intravenous magnesium. Multivariate logistic regression analysis was used to determine the impact of magnesium on ibutilide efficacy as well as the impact of magnesium dosing intensity on ibutilide efficacy. RESULTS: The overall chemical conversion rate with ibutilide in the presence or absence of magnesium was 59.8%. The concurrent administration of magnesium (n = 141) was associated with a 78% increased odds of successful chemical conversion (adjusted odds ratio, AOR; 1.78 [95% confidence intervals,CI 1.02-3.09]) compared to those who did not receive magnesium (n = 88). Magnesium dosing intensity appeared to be an important determinant of ibutilide efficacy, with the 4 grams dose associated with a threefold increase in the odds of successful chemical conversion (AOR; 2.98 [95% CI 1.46-6.11). The 1 to 3 grams subgroup was associated with only a trend toward an improvement. There was only one case of Torsade de Pointes (TdP) which occurred in the no adjunctive magnesium group. CONCLUSIONS: Concurrent use of magnesium enhanced the ability of ibutilide to successfully convert atrial fibrillation (AF) or flutter (AFl). The 4 grams magnesium dose appeared to provide the greatest benefit.
No takes yet. Share an insight, caveat, or question.
Tercius et al. (2007) conducted a cohort in Atrial Fibrillation or Flutter (n=229). Intravenous magnesium sulfate vs. No adjunctive magnesium was evaluated on Successful chemical conversion (AOR 1.78, 95% CI 1.02-3.09). Concurrent administration of intravenous magnesium with ibutilide increased the odds of successful chemical conversion of atrial fibrillation or flutter.
Synapse has enriched 10 related papers. Consider them for comparative context: